Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder UK Mid & Small Cap Fund Regulatory News (SCP)

Share Price Information for Schroder UK Mid & Small Cap Fund (SCP)

Share Price is delayed by 15 minutes
Get Live Data
704.00    3.00 (0.42%)
Bid:
704.00
Ask:
714.00
Spread: 10.00 (1.42%)
Market Cap: £232.33m
SCP Live PriceLast checked at - London Stock Exchange

Intraday Schroder UK Mid & Small Cap Fund Share Chart

Directorate Change

28 Nov 2024 07:02

RNS Number : 9351N
Schroder UK Mid Cap Fund PLC
28 November 2024
 

Thursday, 28 November 2024

 

SCHRODER UK MID CAP FUND PLC

Directorate Change

 

The Board of Schroder UK Mid Cap Fund plc (the "Company") is pleased to announce that Harry Morley has been selected to succeed Robert Talbut as Chair of the Company. Subject to Harry's re-election as a Director at the Annual General Meeting ("AGM") the appointment will be effective from the conclusion of the meeting, to be held on 24 February 2025. Robert Talbut, having served nine years on the Board, will not seek re-election at the forthcoming AGM. The Board thanks Robert for his invaluable contribution and leadership during his time as Chair.

Harry was appointed as a non-executive Director in September 2023 and has since acted as Chair of the Remuneration Committee. The Board has considered Harry's diverse executive experience and is confident that he has the right attributes and knowledge to successfully lead the Board.

Harry was previously CEO of Armajaro Asset Management LLP and was the co-founder and CFO of Tragus Holdings Ltd, owner of Café Rouge and Bella Italia restaurant chains. He also worked in the shipping industry for P&O. He qualified as a chartered accountant with Price Waterhouse. Harry is currently a non-executive Director and Chair of the Audit Committee for JD Wetherspoon plc, and the Senior non-executive Director and Chair of the Audit Committee for TheWorks.co.uk plc.

 

Commenting on the appointment, Wendy Colquhoun, Senior Independent Director, said:

"The Board is very pleased to announce the appointment of Harry as Chair. Harry brings an array of knowledge and experience, paired with a distinguished track record in leadership positions. The Board extends its thanks to Robert for his hard work and diligence over the last nine years."

 

Harry Morley, incoming Chair, said:

I am delighted to succeed Robert as Chair of the Company and would like to thank the Board for appointing me. I am thoroughly looking forward to working with my colleagues to ensure the future success of the Company."

 Enquiries:

Katherine Fyfe / Phoebe Merrell

Schroder Investment Management Limited

020 7658 6000

Charlotte Banks

Schroder Investment Management Limited

020 7658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFEMESWELSEIF
Date   Source Headline
20th Apr 202611:59 amRNSNet Asset Value(s)
17th Apr 20264:40 pmRNSTransaction in Own Shares
17th Apr 202610:56 amRNSNet Asset Value(s)
16th Apr 202610:50 amRNSNet Asset Value(s)
15th Apr 202611:35 amRNSNet Asset Value(s)
14th Apr 20265:20 pmRNSTransaction in Own Shares
14th Apr 202611:42 amRNSNet Asset Value(s)
13th Apr 20264:09 pmRNS-RShareSoc webinar
13th Apr 202611:52 amRNSNet Asset Value(s)
10th Apr 202612:06 pmRNSNet Asset Value(s)
9th Apr 202611:32 amRNSNet Asset Value(s)
8th Apr 20265:21 pmRNSTransaction in Own Shares
8th Apr 202611:51 amRNSNet Asset Value(s)
7th Apr 202611:57 amRNSNet Asset Value(s)
1st Apr 20263:20 pmRNSPortfolio Update
1st Apr 202612:03 pmRNSNet Asset Value(s)
31st Mar 20265:22 pmRNSTotal Voting Rights
31st Mar 20265:20 pmRNSTransaction in Own Shares
31st Mar 202612:01 pmRNSNet Asset Value(s)
30th Mar 20265:20 pmRNSTransaction in Own Shares
30th Mar 202611:47 amRNSNet Asset Value(s)
27th Mar 202611:43 amRNSNet Asset Value(s)
26th Mar 202611:56 amRNSNet Asset Value(s)
25th Mar 202612:01 pmRNSNet Asset Value(s)
24th Mar 20265:08 pmRNSTransaction in Own Shares
24th Mar 202611:54 amRNSNet Asset Value(s)
23rd Mar 202611:56 amRNSNet Asset Value(s)
20th Mar 202611:54 amRNSNet Asset Value(s)
19th Mar 202611:54 amRNSNet Asset Value(s)
18th Mar 202611:45 amRNSNet Asset Value(s)
17th Mar 20264:56 pmRNSHolding(s) in Company
17th Mar 202611:28 amRNSNet Asset Value(s)
16th Mar 20265:09 pmRNSTransaction in Own Shares
16th Mar 202611:51 amRNSNet Asset Value(s)
13th Mar 202611:53 amRNSNet Asset Value(s)
11th Mar 202611:55 amRNSNet Asset Value(s)
9th Mar 202611:47 amRNSNet Asset Value(s)
6th Mar 20265:20 pmRNSPortfolio Update
6th Mar 202611:42 amRNSNet Asset Value(s)
5th Mar 202612:01 pmRNSNet Asset Value(s)
4th Mar 202611:49 amRNSNet Asset Value(s)
3rd Mar 202611:36 amRNSNet Asset Value(s)
2nd Mar 202612:24 pmRNSNet Asset Value(s)
27th Feb 202611:12 amRNSNet Asset Value(s)
26th Feb 202611:48 amRNSNet Asset Value(s)
25th Feb 20264:41 pmRNSResult of AGM
25th Feb 202611:54 amRNSNet Asset Value(s)
24th Feb 202611:43 amRNSNet Asset Value(s)
23rd Feb 202611:40 amRNSNet Asset Value(s)
20th Feb 202610:54 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.